Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Professor Tony Reeve

PositionHonorary Research Professor
DepartmentDepartment of Biochemistry
QualificationsBSc (Cant) MSc PhD (Otago) FRSNZ
Research summaryCancer Genetics, genomics and cancer biology

Research

Professor Tony Reeve has a notable career in cancer research. His work in the Cancer Genetics Laboratory is focussed on the molecular mechanisms of tumour suppressor genes, growth factors, and imprinted genes. He is internationally recognised for his work on Wilms tumour - a paediatric kidney tumour - demonstrating the importance of tumour suppressor genes, growth factor s such as insulin-like growth factor 2, and the disruption that occurs to the genomic imprinting mechanism of specific genes. He also has an interest in cancer genomics particularly as applied to colorectal cancer. By using high throughput gene expression his group showed that low cellular proliferation and an increased adaptive immune response are both hallmarks of poor prognosis for this disease. In addition to the Cancer Genetics Laboratory Professor Reeve also directs the Otago Genomics Facility which specialises in high throughput gene technologies. He played a lead role in establishing NZ Genome Ltd, an infrastructure which will provide a NZ wide network for genome technologies and biostatistical support.

Professor Reeve is a board member of the Health Research Council (NZ) and chair of the Biomedical Research Committee. He is or has served on several editorial boards including Genes Chromosomes and Cancer, Journal of Pediatric Hematology/Oncology, Genomic Medicine, Genome Letters, NZ Medical Journal and The International DNA Methylation Society.

He was awarded the first medal for Health Research in NZ; the Sir Charles Hercus Medal. He is an Honorary member of the NZ Society of Paediatrics, a Fellow of the Royal Society of NZ and was appointed as an Officer of The NZ Order of Merit for services to medical sciences.

Publications

Fukuzawa, R., Anaka, M. R., Morison, I. M., & Reeve, A. E. (2017). The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour. PLoS ONE, 12(10), e0186333. doi: 10.1371/journal.pone.0186333

McInnes, T., Zou, D., Rao, D. S., Munro, F. M., Phillips, V. L., McCall, J. L., Black, M. A., Reeve, A. E., & Guilford, P. J. (2017). Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. BMC Cancer, 17, 228. doi: 10.1186/s12885-017-3226-4

Kuchenbaecker, K. B., Ramus, S. J., Tyrer, J., Lee, A., Shen, H. C., Beesley, J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … for the Consortium of Investigators of Modifiers of BRCA1 and BRCA2. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics, 47(2), 164-171. doi: 10.1038/ng.3185

Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Easton, D. F. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Geoscience, 47, 373-380. doi: 10.1038/ng.3242

Perry, J. R. B., Day, F., Elks, C. E., Sulem, P., Thompson, D. J., Ferreira, T., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Ong, K. K. (2014). Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature, 514, 92-97. doi: 10.1038/nature13545

Chapter in Book - Research

Reeve, A. E. (1995). Genomic imprinting in embryonal and overgrowth disorders. In R. Ohlsson, K. Hall & M. Ritzen (Eds.), Nobel Symposium: Parental Imprinting: Causes and Consequences. (pp. 209-223). Cambridge: Cambridge University Press.

^ Top of page

Journal - Research Article

Fukuzawa, R., Anaka, M. R., Morison, I. M., & Reeve, A. E. (2017). The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour. PLoS ONE, 12(10), e0186333. doi: 10.1371/journal.pone.0186333

McInnes, T., Zou, D., Rao, D. S., Munro, F. M., Phillips, V. L., McCall, J. L., Black, M. A., Reeve, A. E., & Guilford, P. J. (2017). Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. BMC Cancer, 17, 228. doi: 10.1186/s12885-017-3226-4

Kuchenbaecker, K. B., Ramus, S. J., Tyrer, J., Lee, A., Shen, H. C., Beesley, J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … for the Consortium of Investigators of Modifiers of BRCA1 and BRCA2. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics, 47(2), 164-171. doi: 10.1038/ng.3185

Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Easton, D. F. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Geoscience, 47, 373-380. doi: 10.1038/ng.3242

Perry, J. R. B., Day, F., Elks, C. E., Sulem, P., Thompson, D. J., Ferreira, T., … kConFab, including Gardner, M., George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Ong, K. K. (2014). Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature, 514, 92-97. doi: 10.1038/nature13545

Girardin, A., McCall, J., Black, M. A., Edwards, F., Phillips, V., Taylor, E. S., Reeve, A. E., & Kemp, R. A. (2013). Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients. International Journal of Cancer, 132(8), 1842-1850. doi: 10.1002/ijc.27855

Ludgate, J. L., Le Mée, G., Fukuzawa, R., Rodger, E. J., Weeks, R. J., Reeve, A. E., & Morison, I. M. (2013). Global demethylation in loss of imprinting subtype of Wilms tumor. Genes Chromosomes & Cancer, 52(2), 174-184. doi: 10.1002/gcc.22017

Wu, M. K., Sabbaghian, N., Xu, B., Addidou-Kalucki, S., Bernard, C., Zou, D., Reeve, A. E., Eccles, M. R., … Foulkes, W. D. (2013). Biallelic DICER1 mutations occur in Wilms tumours. Journal of Pathology, 230(2), 154-164. doi: 10.1002/path.4196

Kemp, R. A., Black, M. A., McCall, J., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. E. (2011). T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer. Journal of Experimental & Clinical Cancer Research, 30, 78. doi: 10.1186/1756-9966-30-78

Nasri, S., Anjomshoaa, A., Song, S., Guilford, P., McNoe, L., Black, M., Phillips, V., Reeve, A., & Humar, B. (2010). Oligonucleotide array outperforms SNP array on formalin-fixed paraffin-embedded clinical samples. Cancer Genetics & Cytogenetics, 198(1), 1-6. doi: 10.1016/j.cancergencyto.2009.12.002

Fukuzawa, R., Holman, S. K., Chow, C. W., Savarirayan, R., Reeve, A. E., & Robertson, S. P. (2010). WTX mutations can occur both early and late in the pathogenesis of Wilms tumour. Journal of Medical Genetics, 47, 791-794. doi: 10.1136/jmg.2010.080663

Lu, A.-T. T., Salpeter, S. R., Reeve, A. E., Eschrich, S., Johnston, P. G., Barrier, A. J., … Lin, A. Y. (2009). Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis. Clinical Colorectal Cancer, 8(4), 207-214. doi: 10.3816/CCC.2009.n.035

Fukuzawa, R., Anaka, M. R., Weeks, R. J., Morison, I. M., & Reeve, A. E. (2009). Canonical WNT signalling determines lineage specificity in Wilms tumour. Oncogene, 28(8), 1063-1075. doi: 10.1038/onc.2008.455

Anjomshoaa, A., Nasri, S., Humar, B., McCall, J. L., Chatterjee, A., Yoon, H.-S., McNoe, L., Black, M. A., & Reeve, A. E. (2009). Slow proliferation as a biological feature of colorectal cancer metastasis. British Journal of Cancer, 101(5), 822-828. doi: 10.1038/sj.bjc.6605229

Hueber, P.-A., Fukuzawa, R., Elkares, R., Chu, L., Blumentkrantz, M., He, S.-J., Anaka, M. R., Reeve, A. E., Eccles, M. R., … Goodyer, P. R. (2009). PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype. Pediatric & Developmental Pathology, 12(5), 347-354. doi: 10.2350/08-05-0466.1

Anjomshoaa, A., Lin, Y.-H., Black, M. A., McCall, J. L., Humar, B., Song, S., Fukuzawa, R., Yoon, H.-S., … van Rij, A., Thompson-Fawcett, M., & Reeve, A. E. (2008). Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. British Journal of Cancer, 99, 966-973. doi: 10.1038/sj.bjc.6604560

Fukuzawa, R., Anaka, M. R., Heathcott, R. W., McNoe, L. A., Morison, I. M., Perlman, E. J., & Reeve, A. E. (2008). Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. Journal of Pathology, 215(4), 377-387. doi: 10.1002/path.2366

Kawanishi, H., Matsui, Y., Ito, M., Watanabe, J., Takahashi, T., Nishizawa, K., … Guilford, P., Reeve, A., … Ogawa, O. (2008). Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clinical Cancer Research, 14(9), 2579-2587. doi: 10.1158/1078-0432.CCR-07-1922

Humar, B., McNoe, L., Dunbier, A., Heathcott, R., Braithwaite, A. W., & Reeve, A. E. (2008). Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition. Biologics, 2(2), 329-337.

Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., … McCredie, M., … and also Fleming, J., Gardner, M., George, P., Reeve, T., & Robinson, B. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1095. doi: 10.1038/nature05887

Fukuzawa, R., Heathcott, R. W., More, H. E., & Reeve, A. E. (2007). Sequential WT1 and CTNNB1 mutations and alterations of β-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: Two case studies. Journal of Clinical Pathology, 60, 1013-1016.

Lin, H.-M., Chatterjee, A., Lin, Y.-H., Anjomshoaa, A., Fukuzawa, R., McCall, J. L., & Reeve, A. E. (2007). Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncology Reports, 17(6), 1541-1549.

Fukuzawa, R., & Reeve, A. E. (2007). Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. Journal of Pediatric Hematology/Oncology, 29(9), 589-594.

Ito, M., Nishiyama, H., Kawanishi, H., Matsui, S., Guilford, P., Reeve, A., & Ogawa, O. (2007). P21-activated kinase 1: A new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Journal of Urology, 178, 1073-1079.

Matsui, S., Ito, M., Nishiyama, H., Uno, H., Kotani, H., Watanabe, J., Guilford, P., Reeve, A., … Ogawa, O. (2007). Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models. Bioinformatics, 23(6), 732-738.

Humar, B., Fukuzawa, R., Blair, V., Dunbier, A., More, H., Charlton, A., … Reeve, A. E., … Guilford, P. (2007). Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Research, 67(6), 2480-2489. doi: 10.1158/0008-5472.CAN-06-3021

Lin, Y.-H., Friederichs, J., Black, M. A., Mages, J., Rosenberg, R., Guilford, P. J., Phillips, V., Thompson-Fawcett, M., … van Rij, A., Yoon, H.-S., McCall, J. L., … Reeve, A. E. (2007). Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clinical Cancer Research, 13(2), 498-507. doi: 10.1158/1078-0432.CCR-05-2734

Breslow, N. E., Beckwith, J. B., Perlman, E. J., & Reeve, A. E. (2006). Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms Tumor. Pediatric Blood & Cancer, 47, 260-267.

Fukuzawa, R., Heathcott, R. W., Morison, I. M., & Reeve, A. E. (2005). Imprinting, expression, and localisation of DLK1 in Wilms tumours. Journal of Clinical Pathology, 58, 145-150.

Li, W., Kessler, P., Yeger, H., Alami, J., Reeve, A. E., Heathcott, R., … Williams, B. R. G. (2005). A gene expression signature for relapse of primary Wilms tumors. Cancer Research, 65(7), 2592-2601.

Fukuzawa, R., Heathcott, R. W., Sano, M., Morison, I. M., Yun, K., & Reeve, A. E. (2004). Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatric & Developmental Pathology, 7, 125-137.

Fukuzawa, R., Breslow, N. E., Morison, I. M., Dwyer, P., Kusafuka, T., Kobayashi, Y., … Reeve, A. E. (2004). Epigenetic differences between Wilms' tumors in white and east-Asian children. Lancet, 363, 446-451.

Kawakami, T., Zhang, C., Taniguchi, T., Kim, C. J., Okada, Y., Sugihara, H., … Reeve, A. E., … Okamoto, K. (2004). Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene, 23, 6163-6169.

Kawakami, T., Okamoto, K., Kataoka, A., Koizumi, S., Iwaki, H., Sugihara, H., Reeve, A. E., … Okada, Y. (2003). Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes Chromosomes & Cancer, 38, 97-101.

Futschik, M. E., Sullivan, M., Reeve, A., & Kasabov, N. (2003). Prediction of clinical behaviour and treatment for cancers. Applied Bioinformatics, 2(3, Suppl.), S53-S58.

Kawakami, T., Okamoto, K., Sugihara, H., Hattori, T., Reeve, A. E., Ogawa, O., & Okada, Y. (2003). The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. Journal of Urology, 169(4), 1546-1552.

Futschik, M. E., Reeve, A. E., & Kasabov, N. K. (2003). Evolving connectionist systems for knowledge discovery from gene expression data of cancer tissue. Artificial Intelligence in Medicine, 28, 165-189.

Fukuzawa, R., Hata, J.-I., Hayashi, Y., Ikeda, H., & Reeve, A. E. (2003). Beckwith-Wiedemann syndrome-associated hepatoblastoma: Wnt signal activation occurs later in tumorigenesis in patients with 11p15.5 uniparental disomy. Pediatric & Developmental Pathology, 6, 299-306.

Morison, I. M., Ellis, L., Teague, L. R., & Reeve, A. E. (2002). Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia. Blood, 99(1), 375-377.

Futschik, M., Jeffs, A., Pattison, S., Kasabov, N., Sullivan, M., Merrie, A., & Reeve, A. (2002). Gene expression profiling of metastatic and nonmetastatic colorectal cancer cell lines. Genome Letters, 1(1), 26-34. doi: 10.1166/gl.2002.005

Kerr, N. J., Chun, Y.-H., Yun, K., Heathcott, R. W., Reeve, A. E., & Sullivan, M. J. (2002). Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression. Medical & Pediatric Oncology, 39, 52-54.

Heathcott, R. W., Morison, I. M., Gubler, M. C., Corbett, R., & Reeve, A. E. (2002). A review of the phenotypic variation due to the Denys-Drash Syndrome-associated germline WT1 mutation R362X. Human Mutation, 19(4), 462.

Delahunt, B., Kittelson, J. M., McCredie, M. R. E., Reeve, A. E., Stewart, J. H., & Bilous, A. M. (2002). Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: Assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer, 94(3), 658-664.

Reeve, A. E., Becroft, D. M. O., Morison, I. M., & Fukuzawa, R. (2002). IGF2 imprinting in cancer. Lancet, 359, 2050-2051.

Mitsumori, K., Kittelson, J. M., Itoh, N., Delahunt, B., Heathcott, R., Stewart, J. H., McCredie, M. R. E., & Reeve, A. E. (2002). Chromosome 14q LOH in localized clear cell renal cell carcinoma. Journal of Pathology, 198, 110-114.

Pattison, S. T., & Reeve, A. E. (2001). From molecule to malady. The future of high speed molecular biology in medicine. New Zealand Medical Journal, 114, 70-72.

Itoh, N., Becroft, D. M. O., Reeve, A. E., & Morison, I. M. (2000). Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-Beckwith Syndrome. American Journal of Medical Genetics, 92, 111-116.

Morison, I. M., Eccles, M. R., & Reeve, A. E. (2000). Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis. Blood, 96(9), 3023-3028.

Rapley, E. A., Barfoot, R., Bonaite-Pellie, C., Chompret, A., Foulkes, W., Perusinghe, N., Reeve, A., … Rahman, N. (2000). Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2. British Journal of Cancer, 83(2), 177-183. doi: 10.1054/bjoc.2000.1283

Frevel, M. A. E., Hornberg, J. J., & Reeve, A. E. (1999). A potential imprint control element: identification of a conserved 42 bp sequence upstream of H19. Trends in Genetics, 15(6), 216-218.

Sullivan, M. J., Taniguchi, T., Jhee, A., Kerr, N., & Reeve, A. E. (1999). Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene, 18, 7527-7534.

Gardner, R. J. M., Gaff, C. L., Macrae, F. A., St John, D. J. B., Hopkins, J., Guilford, P. J., & Reeve, A. E. (1999). E-cadherin unlikely to be a common "low penetrance" gene for colorectal cancer. American Journal of Medical Genetics, 84(2), 169-171.

Shinmura, K., Kohno, T., Takahashi, M., Sasaki, A., Ochiai, A., Guilford, P., Hunter, A. K., Reeve, A. E., … Yokota, J. (1999). Familial gastric cancer: Clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis, 20(6), 1127-1131. doi: 10.1093/carcin/20.6.1127

Benjes, S. M., Millow, L. J., Jeffs, A. R., Sowerby, S. J., Reeve, A. E., & Morris, C. M. (1999). 3' BCR recombines with IGL locus in BCR-ABL-positive Philadelphia-negative chronic myeloid leukaemia. Genes Chromosomes & Cancer, 26(4), 366-371.

Guilford, P. J., Hopkins, J. B. W., Grady, W. M., Markowitz, S. D., Willis, J., Lynch, H., … Toro, T. T., … Shaw, D. P., Findlay, M. P. N., & Reeve, A. E. (1999). E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Human Mutation, 14(3), 249-255. doi: 10.1002/(SICI)1098-1004

Frevel, M. A. E., Sowerby, S. J., Petersen, G. B., & Reeve, A. E. (1999). Methylation sequencing analysis refines the region of H19 epimutation in Wilms Tumor. Journal of Biological Chemistry, 274(41), 29331-29340.

Yun, K., Soejima, H., Gunn, J., Merrie, A. E. H., McCall, J. L., & Reeve, A. E. (1999). Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific PCR. Journal of Pathology, 187, 518-522.

Guilford, P., Hopkins, J. B. W., Harraway, J., McLeod, M., McLeod, N., Harawira, P., … Miller, A., & Reeve, A. E. (1998). E-cadherin germline mutations in familial gastric cancer. Nature, 392(6674), 402-405. doi: 10.1038/32918

Okamoto, K., Morison, I. M., Taniguchi, T., & Reeve, A. E. (1997). Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. PNAS, 94(10), 5367-5371.

Taniguchi, T., Okamoto, K., & Reeve, A. E. (1997). Human p57KIP2 defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene, 14(10), 1201-1206.

Mishina, M., Ogawa, O., Kinoshita, H., Oka, H., Okumura, K., Mitsumori, K., … Reeve, A. E., & Yoshida, O. (1996). Equivalent parental distribution of frequently lost alleles and biallelic expression of the H19 gene in human testicular germ cell tumors. Japanese Journal of Cancer Research, 87(8), 816-823.

Reeve, A. E. (1996). Role of genomic imprinting in Wilms' Tumour and overgrowth disorders. Medical & Pediatric Oncology, 27(5), 470-475.

Morison, I. M., Becroft, D. M., Taniguchi, T., Reeve, A. E., & Woods, C. G. (1996). Somatic overgrowth associated with overexpression of insulin—like growth factor II. Nature Medicine, 2, 311-316. doi: 10.1038/nm0396-311

Becroft, D. M. O., Mauger, D. C., Skeen, J. E., Ogawa, O., & Reeve, A. E. (1995). Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene. Pediatric Pathology & Laboratory Medicine, 15, 679-688.

Simms, L. A., Reeve, A. E., & Smith, P. J. (1995). Genetic mosaicism at the Insulin locus in liver associated with childhood hepatoblastoma. Genes Chromosomes & Cancer, 13, 72-73.

Taniguchi, T., Schofield, A. E., Scarlett, J. L., Morison, I. M., Sullivan, M. J., & Reeve, A. E. (1995). Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour. Oncogene, 11, 751-756.

Taniguchi, T., Sullivan, M. J., Ogawa, O., & Reeve, A. E. (1995). Epigenetic changes encompassing the IGF/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. PNAS, 92(6), 2159-2163.

^ Top of page

Journal - Research Other

Fukuzawa, R., Reeve, A. E., & Morison, I. M. (2005). Correct usage of ″Loss of imprinting″ [Correspondence]. American Journal of Medical Genetics, 138A, 412.

Kawakami, T., Okamoto, K., Sugihara, H., Hattori, T., Reeve, A. E., Ogawa, O., & Okada, Y. (2004). The MET proto-oncogene is not a major target for the gain of chromosome 7 in testicular germ-cell tumors of adolescents [Letter]. Virchows Archiv, 444, 480-481.

Fukuzawa, R., Heathcott, R. W., Morison, I. M., Reeve, A. E., & Sano, M. (2004). Reply to Dr. Sredni and colleagues. Pediatric & Developmental Pathology, 7, 670.

Kerr, N. J., Fukazawa, R., Reeve, A. E., & Sullivan, M. J. (2002). Beckwith-Wiedemann syndrome' pancreatoblastoma, and the Wnt signaling pathway [Letter to the editor]. American Journal of Pathology, 160(4), 1541.

More publications...